GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » 1CM Inc (XCNQ:EPIC) » Definitions » EBITDA Margin %

1CM (XCNQ:EPIC) EBITDA Margin % : 2.85% (As of May. 2024)


View and export this data going back to 2012. Start your Free Trial

What is 1CM EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. 1CM's EBITDA for the three months ended in May. 2024 was C$0.43 Mil. 1CM's Revenue for the three months ended in May. 2024 was C$15.01 Mil. Therefore, 1CM's EBITDA margin for the quarter that ended in May. 2024 was 2.85%.


1CM EBITDA Margin % Historical Data

The historical data trend for 1CM's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

1CM EBITDA Margin % Chart

1CM Annual Data
Trend Aug14 Aug15 Aug16 Aug17 Aug18 Aug19 Aug20 Aug21 Aug22 Aug23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23,741.18 - -1,043.27 -399.41 3.72

1CM Quarterly Data
Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.83 15.33 0.30 3.30 2.85

Competitive Comparison of 1CM's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, 1CM's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


1CM's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, 1CM's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where 1CM's EBITDA Margin % falls into.



1CM EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

1CM's EBITDA Margin % for the fiscal year that ended in Aug. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Aug. 2023 )/Revenue (A: Aug. 2023 )
=1.314/35.341
=3.72 %

1CM's EBITDA Margin % for the quarter that ended in May. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: May. 2024 )/Revenue (Q: May. 2024 )
=0.428/15.011
=2.85 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


1CM  (XCNQ:EPIC) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


1CM EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of 1CM's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


1CM Business Description

Traded in Other Exchanges
Address
625 Cochrane Drive, Suite 802, Markham, ON, CAN, L3R9R9
1CM Inc is a multi-jurisdictional cannabis company focused on it's retail customers and technology to democratize cannabis markets. The Company is focuses on expanding its current operations through organic growth and by way of merger and acquisition transactions.

1CM Headlines

No Headlines